Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Resources
Our Tools
Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Contact

Search for:

∕
Knowledge Base
∕
Co-morbid substance use disorders

Topic: Co-morbid substance use disorders

Knowledge Base (Individuals+Families)

50 result(s) found.

What are the best ways of helping people with serious mental illnesses quit tobacco?
What is the best practice for treatment of co-occurring disorders?
What are the challenges of patients accepting medication assisted treatment (MAT) for their opiate use disorder?
Does smoking cigarettes really interfere with how well medication for schizophrenia works?
What are smoking cessation tools for those with schizophrenia?
Is substance abuse common in people with schizophrenia?
If marijuana is legal, is it ok for patients with serious mental illness to use it?
What are available practice guidelines for substance abuse disorder?
Can effective peer support be provided for individuals with co-occurring mental health and substance use disorders?
In lethal opioid overdoses, how do you differentiate between suicide by overdose and “accidental” overdoses?
Is there anything I should know about smoking, tobacco or nicotine and clozapine?
There is a known association between depression and pain but is there also a connection between bipolar disorder and pain?
How do I get insurance to cover mental health and substance use disorder treatment?
Decisions in Recovery: Treatment for Opioid Use Disorder
What are the treatment options for managing pain in a patient with opioid use disorder who is hospitalized?
What should primary care providers know how to do if they are working in mental health setting?
What is the relationship between PTSD and pain?
Is there a healthcare model that can treat medical problems, mental health conditions and substance use disorders at the same time and place?
What’s the best way to deal with a young person who is struggling with BOTH a substance use disorder and a psychiatric illness?
How does opioid use disorder increase the risk of contracting Hepatitis C and HIV?
Is it possible to receive primary care inside an opiate treatment program?
How do you optimize the clinical management of persons opioid use disorders (OUD) and co-occurring psychiatric disorders who are actively using opioids and are experiencing significant pain?
How do primary care providers and mental health experts feel about opioid and benzodiazepines co-prescribing?
How to screen and assess SUD in adolescents?
How does the collaborative care model improve treatment access for people with substance use disorders?
For patients on MAT, how can behavioral treatment protocols be effective in supporting recovery?
If patients with opioid use disorders are detoxified successfully, why should they take medications rather than remaining “completely abstinent”?
How should doctors and their patients decide on the most appropriate pharmacological treatment with opioid use disorder?
What interventions address stigma in addictions?
How can psychosocial interventions contribute to improving medication assisted treatment outcomes in patients with SUD?
How should urine drug testing be used in clinical practice?
What are the office procedures that should be followed when prescribing buprenorphine?
Why should urine drug screening be done in clinical practice?
What are four things that can be done to address the opioid epidemic?
How can telepsychiatry be used to treat addictive disorders?
What is Smart Recovery and isn’t it the same as AA?
How can healthcare providers prevent acute pain from becoming chronic pain?
What support options are available for healthcare providers with substance use disorders?
What are the components of a self-management approach to chronic pain?
What is an example of a program that has worked in to increase access for the treatment of substance use disorders?
Kansas Tobacco Guideline for Behavioral Heath Care: An Implementation Toolkit
What is the evidence for cannabinoids for the treatment of SMI and symptoms of SMI?
Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
What happens to a young person who is experiencing a first onset of psychotic symptoms and then starts using or abusing alcohol, cannabis or other substances?
Is there a connection between a young person’s use of cannabis (marijuana) or cannabinoids and a first onset of psychosis?
What is known about patients with serious mental illness who drink too much (polydipsia)?
Is there cause to be concerned about smoking among people with mental illness?
What resources are available to raise awareness of individuals, caregivers and the community about the dangers of smoking and mental illness?
Implementing Tobacco Cessation Programs in Substance Use Disorder Treatment Settings
How many individuals who have serious mental illness also have a substance use disorder?

Administered by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.